Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study tests a new antibody drug called SSGJ-626 in people with systemic lupus erythematosus (SLE). The goal is to see if it is safe and can help control the disease. About 198 adults aged 18 to 70 with SLE will receive either the drug or a placebo. The study is currently rec…

This study tests a new drug called 608 in 500 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants will receive either 608 or a placebo to see if the drug improves symptoms like pain and mobility. The goal is to find a b…

This study tests a new medication called 611 in Chinese teenagers aged 12 to 17 with moderate-to-severe atopic dermatitis (eczema). The drug aims to reduce skin redness, itching, and rash by blocking a protein involved in inflammation. Participants will receive either 611 or a pl…

This study tests a new drug, 611, in 594 Chinese adults with moderate to severe COPD. The goal is to see if it can reduce the number of serious flare-ups and improve breathing. Participants will receive either 611 or a placebo, and their lung function and exacerbation rates will …

This study tests a new drug called 610 in 480 Chinese adults with severe eosinophilic asthma. The goal is to see if it reduces the number of serious asthma attacks over one year compared to a placebo. Participants must have had asthma for at least a year and be using regular inha…